Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT

Malladi, Srinivas, Macalinao, Danilo G., Jin, Xin, He, Lan, Basnet, Harihar, Zou, Yilong, de Stanchina, Elisa, Massagué, Joan·2016·Cell

Cited by (790)

Items 301–400 of 790

  1. The Complexities of Metastasis
    Beatriz P. San Juan, María Jesús García-León, Laura Rangel, Jacky G. Goetz, Christine Louise Chaffer · 2019 · Cancers
  2. Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer
    Beatrice Gini, Nicholas J. Thomas, Collin Michael Blakely · 2020 · Journal of Thoracic Disease
  3. The Brain Microenvironment Induces DNMT1 Suppression and Indolence of Metastatic Cancer Cells
    E. Hirata, Kojiro Ishibashi, S. Kohsaka, K. Shinjo, S. Kojima, Y. Kondo, H. Mano, S. Yano, E. Kiyokawa, E. Sahai · 2020 · iScience
  4. Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse
    Andrea R. Lim, Cyrus Michael Ghajar · 2021 · Seminars in Cancer Biology
  5. The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape
    Sara Bruschini, Gennaro Ciliberto, Rita Mancini · 2020 · Cell Death and Disease
  6. Microenvironment-mediated cancer dormancy: Insights from metastability theory
    Sadra Bakhshandeh, Carsten Werner, Peter Fratzl, Amaia Cipitria · 2021 · Proceedings of the National Academy of Sciences
  7. The tumor as organizer model
    Jinyang Li, Ben Z. Stanger · 2019 · Science
  8. Wnt Signaling in the Development of Bone Metastasis
    Noa Ben-Ghedalia-Peled, Razi Vago · 2022 · Cells
  9. Animal models of brain metastasis
    Lauritz Miarka, Manuel Valiente · 2021 · Neuro-Oncology Advances
  10. Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer
    Alexander Ring, Maria Spataro, Andreas N. WICKI, Nicola Aceto · 2022 · Frontiers in Cell and Developmental Biology
  11. Molecular mechanisms of ovarian carcinoma metastasis: Key genes and regulatory microRNAs
    Брага Элеонора Александровна, Marina V. Fridman, Н. Е. Кушлинский · 2017 · Biochemistry (Moscow)
  12. Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
    Euphemia Yee Leung, Marjan Askarian-Amiri, Debina Sarkar, Carole Ferraro‐Peyret, Wayne R. Joseph, Graeme J. Finlay, Bruce C. Baguley · 2017 · Frontiers in Oncology
  13. Dopamine D1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness
    Liang Yang, Ye Yao, Ling Yong, Yaoyao Feng, Hong Su, Qingyu Yao, Junsheng Xue, Wei Lu, Tianyan Zhou · 2019 · European Journal of Pharmacology
  14. Antimetastatic defense by CD8+ T cells
    Paulino Tallón de Lara, Héctor Castañón, Michelle Sterpi, Maries F. van den Broek · 2021 · Trends in cancer
  15. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy
    Laura Vera Ramírez · 2019 · Seminars in Cancer Biology
  16. Immunosurveillance encounters cancer metabolism
    Yu‐Ming Chuang, Sheue‐Fen Tzeng, Ping‐Chih Ho, Chin‐Hsien Tsai · 2024 · EMBO Reports
  17. CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases
    Tao Shi, Wei Liu, Yuting Luo, Kaijie Liang, Shiji Ren, Xueru Song, Fangcen Liu, Chun Lu, Daniel Hirschhorn, Hanbing Wang et al. · 2025 · Cancer Cell
  18. Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
    Juliane Lehmann, Sylvia Thiele, Ulrike Baschant, Tilman D. Rachner, Christof Niehrs, Lorenz Christian Hofbauer, Martina Rauner · 2021 · iScience
  19. Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes
    L. Jahangiri, Tala Ishola · 2022 · International Journal of Molecular Sciences
  20. A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression
    Yu Liu, Peter John, Kenta Nishitani, Jihong Cui, Christopher Nishimura, John R. Christin, Nicole Couturier, Xiaoxin Ren, Wei Yao, Marc C. Pulanco et al. · 2023 · Developmental Cell
  21. SOX on tumors, a comfort or a constraint?
    Junqing Jiang, Yufei Wang, Mengyu Sun, Xiangyuan Luo, Zerui Zhang, Yijun Wang, Siwen Li, Dian Xing Hu, Jiaqian Zhang, Zhangfan Wu et al. · 2024 · Cell Death Discovery
  22. Metastatic Latency, a Veiled Threat
    Kangsan Kim, Mauricio Marquez-Palencia, Srinivas Malladi · 2019 · Frontiers in Immunology
  23. Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy
    Martina Molgora, Victor S. Cortez, Marco Colonna · 2021 · Cancers
  24. Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease
    Josef Leibold, Kaloyan M. Tsanov, Corina Amor, Yu-Jui Ho, Francisco J. Sánchez Rivera, Judith Feucht, Timour Baslan, Hsuan-An Chen, Sha Tian, Janelle M. Simon et al. · 2024 · Nature Cancer
  25. Bone serves as a transfer station for secondary dissemination of breast cancer
    Yufan Huang, Hongli Wang, Xiaomin Yue, Xiaoqing Li · 2023 · Bone Research
  26. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy
    K. Dzobo, N. Thomford, D. Senthebane · 2019 · Omics
  27. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications
    Nathaniel J Robinson, Kimberly A. Parker, William P. Schiemann · 2020 · Annals of Translational Medicine
  28. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
    Marta Gomarasca, Paola Maroni, Giuseppe Banfi, Giovanni Lombardi · 2020 · International Journal of Molecular Sciences
  29. Dickkopf-1 promotes Vascular Smooth Muscle Cell proliferation and migration through upregulating UHRF1 during Cyclic Stretch application
    Tengfei Zheng, Xiaolin Liu, Xiao Li, Qianqian Wang, Yachao Zhao, Xuan Li, Mengmeng Li, Yu Zhang, Meng Zhang, Wencheng Zhang et al. · 2021 · International Journal of Biological Sciences
  30. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective
    Chiara Donini, Ramona Rotolo, Alessia Proment, Massimo Aglietta, Dario Sangiolo, Valeria Leuci · 2021 · Cells
  31. Means to the ends: The role of telomeres and telomere processing machinery in metastasis
    Nathaniel J Robinson, William P. Schiemann · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  32. Elevating SOX2 in prostate tumor cells upregulates expression of neuroendocrine genes, but does not reduce the inhibitory effects of enzalutamide
    Ethan P. Metz, Phillip J. Wilder, Jixin Dong, Kaustubh Datta, Angie Rizzino · 2019 · Journal of Cellular Physiology
  33. Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer
    Yipeng Zhang, Kaijie Liang, Xiaoyu Zhou, Xin Zhang, Hui Jie Xu, Hongjiu Dai, Xueru Song, Xueyi Yang, Baorui Liu, Tao Shi et al. · 2023 · Cancer Science
  34. Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
    Brooke E. Wilson, Chiara Gorrini, David W. Cescon · 2021 · Breast Cancer Research and Treatment
  35. The Role of the Innate Immune System in Cancer Dormancy and Relapse
    Noah M. Chernosky, Ilaria Tamagno · 2021 · Cancers
  36. PHLDB2 Mediates Cetuximab Resistance via Interacting With EGFR in Latent Metastasis of Colorectal Cancer
    Maochao Luo, Zhao Huang, Xingyue Yang, Yan Chen, Jingwen Jiang, Lu Zhang, Li Zhou, Siyuan Qin, Ping Jin, Shuyue Fu et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  37. Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment
    Nasim Ebrahimi, Kamyar Kharazmi, Masoud Ghanaatian, Seyed Ali Miraghel, Yasaman Amiri, Seyede Sanaz Seyedebrahimi, Halimeh Mobarak, Elnaz Yazdani, Sahar Parkhideh, Michael Richard Hamblin et al. · 2022 · Cytokine & Growth Factor Reviews
  38. STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation
    En-di Zhang, Chenxuan Li, Yuan Fang, Na Li, Zhongyun Xiao, Chuhong Chen, Benkai Wei, Hangping Wang, Jincheng Xie, Yinglei Miao et al. · 2022 · World Journal of Surgical Oncology
  39. Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
    Anna Borgenvik, Karl O. Holmberg, Sara Bolin, Miao Zhao, Vasil Savov, Gabriela Rosén, Sonja Hutter, Alexandra Garancher, Aldwin Suryo Rahmanto, Tobias Bergström et al. · 2022 · Cancer Research
  40. Collagen Mineralization Decreases NK Cell‐Mediated Cytotoxicity of Breast Cancer Cells via Increased Glycocalyx Thickness
    Sangwoo Park, Siyoung Choi, Adrian A. Shimpi, Lara A. Estroff, Claudia Fischbach, Matthew J. Paszek · 2024 · Advanced Materials
  41. Cancer brain metastasis: molecular mechanisms and therapeutic strategies
    Yucheng Lu, Yunhang Huang, Chenyan Zhu, Zhidan Li, Bin Zhang, Hui Sheng, Haotai Li, Xixi Liu, Zhongwen Xu, Yi Wen et al. · 2025 · Molecular Biomedicine
  42. TGFβ induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis
    Zhenghan Wang, Yassmin A. Elbanna, Inês Godet, Siting Gan, Lila Peters, George D. Lampe, Yanyan Chen, João B. Xavier, Morgan Huse, Joan Massagué · 2026 · Nature Cancer
  43. Brain metastasis models: What should we aim to achieve better treatments?
    Mariam Masmudi‐Martín, Lucía Zhu, Macarena Sánchez‐Navarro, Neibla Priego, María Casanova-Acebes, Victor Ruiz‐Rodado, Ernest Giralt, Manuel Valiente · 2020 · Advanced Drug Delivery Reviews
  44. Tumor Microenvironment–Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy
    Yuting Tang, Qian Xu, Liang Hu, Xiaomei Yan, Xiaomin Feng, Asumi Yokota, Weinan Wang, Di Zhan, Durga Krishnamurthy, David E. Ochayon et al. · 2021 · Cancer Discovery
  45. DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma
    Rebecca Christian Arend, Jhalak Dholakia, Cesar Castro, Ursula A. Matulonis, Erika Paige Hamilton, Camille Gunderson Jackson, Kristopher Lybarger, Howard M. Goodman, Linda Duska, Haider Mahdi et al. · 2023 · Gynecologic Oncology
  46. Immune surveillance of brain metastatic cancer cells is mediated by IFITM1
    Xiaofei She, Shijun Shen, Guang Chen, Yaqun Gao, Junxian Ma, Yaohui Gao, Yingdi Liu, Guoli Gao, Yan Fang Zhao, Chunyan Wang et al. · 2023 · The EMBO Journal
  47. Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
    Xuetong Shen, Chundi Gao, Huayao Li, Cun Liu, Longyun Wang, Ye Li, Ruijuan Liu, Changgang Sun, Jing Zhuang · 2023 · Frontiers in Pharmacology
  48. Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention
    Ravikanth Maddipati · 2025 · Journal of Clinical Investigation
  49. Predicting Axillary Lymph Node Metastasis in Patients With Breast Invasive Ductal Carcinoma With Negative Axillary Ultrasound Results Using Conventional Ultrasound and Contrast‐Enhanced Ultrasound
    An‐Qi Zhu, Xiao‐Long Li, Liwei An, Le‐Hang Guo, Hui‐Jun Fu, Liping Sun, Hui‐Xiong Xu · 2020 · Journal of Ultrasound in Medicine
  50. The dual role of complement in cancers, from destroying tumors to promoting tumor development
    Ping Lü, Yifei Ma, Shaozhong Wei, Xinjun Liang · 2021 · Cytokine
  51. Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation
    Frank Cameron Cackowski, Russell S. Taichman · 2018 · Bone
  52. Mammary Stem Cells and Breast Cancer Stem Cells: Molecular Connections and Clinical Implications
    Toni Celià-Terrassa · 2018 · Biomedicines
  53. Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions
    Kha‐Liang Lee, Gao Chen, Tai‐Yuan Chen, Yung‐Che Kuo, Yu-Kai Su · 2020 · Cancers
  54. Awakening of Dormant Breast Cancer Cells in the Bone Marrow
    Robert Wieder · 2023 · Cancers
  55. Angelica sinensis polysaccharide suppresses the Wnt/β-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis.
    Yan Cai, Yang Wang, Wenjun Su, Xiang-Ling Zhou, Chunfeng Lu · 2024 · Biochemical Pharmacology
  56. An immunosuppressive pathway for tumor progression
    Antoine Marçais, Thierry Walzer · 2018 · Nature Medicine
  57. SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance
    Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar Biswal · 2022 · Drug Discovery Today
  58. Mechanoregulation of Metastasis beyond the Matrix
    Ekrem Emrah Er, María Tello‐Lafoz, Morgan Huse · 2022 · Cancer Research
  59. Cell Competition Shapes Metastatic Latency and Relapse
    Kangsan Kim, Huocong Huang, Pravat Kumar Parida, Lan He, Mauricio Marquez-Palencia, Tanner C. Reese, Payal Kapur, James Brugarolas, Rolf A. Brekken, Srinivas Malladi · 2022 · Cancer Discovery
  60. Sox2 dosage: A critical determinant in the functions of Sox2 in both normal and tumor cells
    Ethan P. Metz, Angie Rizzino · 2019 · Journal of Cellular Physiology
  61. Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation
    Dijkstra, Jelmer J., Neikes, Hannah K., Rezaeifard, Somayeh, Ma, Xuhui, Voest, Emile E., Tauriello, Daniele V. F., Vermeulen, Michiel · 2023 · Journal of Proteome Research
  62. The epigenetic landscape of brain metastasis
    Aoibhín M. Powell, Louise Watson, Lara Luzietti, Stefan Preković, Leonie S. Young, Damir Varešlija · 2025 · Oncogene
  63. The immunology of brain tumors
    Lukas Bunse, Theresa Bunse, Michael Kilian, Francisco Javier Quintana, Michael Platten · 2025 · Science Immunology
  64. Could Extracellular Vesicles Contribute to Generation or Awakening of “Sleepy” Metastatic Niches?
    Alberto Hernández‐Barranco, Laura Nogués, Héctor Peinado · 2021 · Frontiers in Cell and Developmental Biology
  65. Prostate Cancer Dormancy and Reactivation in Bone Marrow
    Deepak Kumar Singh, Vaibhav G. Patel, William K. Oh, Julio A. Aguirre‐Ghiso · 2021 · Journal of Clinical Medicine
  66. Modulation of Immune Components on Stem Cell and Dormancy in Cancer
    Xiaofan Jiang, Lu Liang, Guanglei Chen, Caigang Liu · 2021 · Cells
  67. Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
    Lourdes Cortes‐Dericks, Domenico Galetta · 2022 · Cancers
  68. Involvement of redox signalling in tumour cell dormancy and metastasis
    Beatriz Puente-Cobacho, Alfonso Varela‐López, José Luis Quiles, Laura Vera Ramírez · 2023 · Cancer and Metastasis Reviews
  69. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
    Zhaohui Chen, Yao Tian, Guang-Lei Zhou, Hao-Ran Yue, Xue-Jie Zhou, Haiyan Ma, Jie Ge, Xin Wang, Xuchen Cao, Yue Yu · 2023 · Breast Cancer Research
  70. AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
    Wenwen Tian, Yuhui Tang, Yongzhou Luo, Jindong Xie, Shaoquan Zheng, Yutian Zou, Xiaojia Huang, Linyu Wu, Junsheng Zhang, Yuying Sun et al. · 2023 · Cell Death and Disease
  71. Surrogate R-spondins for tissue-specific potentiation of Wnt Signaling
    Vincent C. Luca, Yi Miao, Xingnan Li, Michael J. Hollander, Calvin Jay Kuo, K. Christopher García · 2020 · PLoS ONE
  72. Unravelling the Mysteries of the Sonic Hedgehog Pathway in Cancer Stem Cells: Activity, Crosstalk and Regulation
    Carlo Berrino, Aadilah Omar · 2024 · Current Issues in Molecular Biology
  73. Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity
    Anna‐Marie Pedde, Hyunu Kim, Sainitin Donakonda, Tobias Baumann, Felix Bayerl, Philippa Meiser, Anna Hirschberger, Christine Klement, Simon A. Grassmann, Rupert Öllinger et al. · 2024 · Cell Reports
  74. Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis
    Yu Liang, Wo‐Ming Chen, Youming Zhang, Lei Li · 2026 · Signal Transduction and Targeted Therapy
  75. A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer
    Dimitrios K. Korentzelos, Amanda M. Clark, Alan H. Wells · 2020 · International Journal of Molecular Sciences
  76. The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
    Florian Wegwitz, Evangelos Prokakis, Anastasija Pejkovska, Robyn Laura Kosinsky, Markus Glatzel, Klaus Pantel, Harriet Wikman, Steven A. Johnsen · 2020 · Cell Death and Disease
  77. The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
    Rodion A. Velichinskii, Maria A. Streltsova, Sofya A. Kust, Alexander M. Sapozhnikov, Elena I. Kovalenko · 2021 · International Journal of Molecular Sciences
  78. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer
    Lingling Zu, Jinling He, Ning Zhou, Quanying Tang, Maoli Liang, Song Xu · 2023 · Cell Death and Disease
  79. Dual-Functional Fluorescent Probe in the Diagnosis of Liver Injury and the Evaluation of Drug Therapy with Double Signal Amplification
    Chenchen Bian, Miaomiao Liu, Jiayi Cheng, Lei Yang, Zhanxian Li, Mingming Yu · 2024 · Chemical & Biomedical Imaging
  80. AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer
    Mauricio Marquez-Palencia, Luis Reza Herrera, Pravat Kumar Parida, Suvranil Ghosh, Kangsan Kim, Nikitha M. Das, Paula I. González Ericsson, Melinda E. Sanders, Bret C. Mobley, Sebastian Diegeler et al. · 2024 · Cancer Research
  81. Liver Metastasis in Cancer: Molecular Mechanisms and Management
    Wen-Chao Xu, Jia Xu, Jian-Zhou Liu, Nanzhou Wang, Li Zhou, Jun-Chao Guo · 2025 · MedComm
  82. Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities
    Sivapar V. Mathan, Rana Pratap Singh · 2025 · Cancers
  83. TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
    Catalina Rozalén, Irene Sangrador, Silvia Avalle, Sandra Blasco-Benito, Panagiota Tzortzi, María Sanz‐Flores, José Ángel Palomeque, Pau Torren-Duran, Mariona Dalmau, Héléna Brunel et al. · 2025 · Cancer Cell
  84. SOX factors as cell-state regulators in the mammary gland and breast cancer
    Yu Liu, Wenjun Guo · 2021 · Seminars in Cell and Developmental Biology
  85. Immune Modulation of Metastatic Niche Formation in the Bone
    Xinyu Cheng, Zhan Wang · 2021 · Frontiers in Immunology
  86. Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory
    Valentina Artusa, Luana Calabrone, Lorenzo Mortara, Francesco Peri, Antonino Bruno · 2023 · International Journal of Molecular Sciences
  87. Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells
    Yuna Kim, Yoo Jin Bae, Jie‐Hyun Kim, Hyunki Kim, Su‐Jin Shin, Da Hyun Jung, Hyojin Park · 2023 · BMC Cancer
  88. The role of liver cancer stem cells in hepatocellular carcinoma metastasis
    Qinghui Niu, Susu Ye, Zhao Liu, Yanzhi Qian, Fengchao Liu · 2024 · Cancer Biology & Therapy
  89. Outlook and opportunities for engineered environments of breast cancer dormancy
    Nathan R. Richbourg, Ninette Irakoze, Hyuna Kim, Shelly R. Peyton · 2024 · Science Advances
  90. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen
    Richard Harrop, Eric E. O’Neill, Peter L. Stern · 2019 · Therapeutic Advances in Vaccines and Immunotherapy
  91. Role of STING in the treatment of non-small cell lung cancer
    Wenhua Tang, Wenjie Zhou, Mei Ji, Xin Yang · 2024 · Cell Communication and Signaling
  92. Immunotherapy in lung cancer brain metastases
    Eunice Paisana, Rita Cascão, Magda Alvoeiro, Francisco Félix, Guilherme Martins, Carla Guerreiro, Rafael Roque, Rafael Cruz, Teresa R. Pacheco, Ana Cristina Amado et al. · 2025 · npj Precision Oncology
  93. Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells
    Haojun Shi, Yisi Yang · 2021 · Cancer Medicine
  94. ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β‐catenin signaling pathway
    Jinbao Xie, Guoliang Liao, Zhi Feng, Bo Liu, Xu Li, Minglian Qiu · 2022 · Molecular Carcinogenesis
  95. Cancer stem cell plasticity and its implications in the development of new clinical approaches for oral squamous cell carcinoma
    Henry Marles, Adrian Biddle · 2022 · Biochemical Pharmacology
  96. Forces at play: exploring factors affecting the cancer metastasis
    Farooq Riaz, Jing Zhang, Fan Pan · 2024 · Frontiers in Immunology
  97. GREMI: an Explainable Multi-omics Integration Framework for Enhanced Disease Prediction and Module Identification
    Hong Liang, Haoran Luo, Z. Sang, M. Jia, Xiao-Han Jiang, Zheng Wang, Shan Cong, Xiao-Hui Yao · 2023 · bioRxiv
  98. Membrane‐bound Dickkopf‐1 in Foxp3+ regulatory T cells suppresses T‐cell‐mediated autoimmune colitis
    Wook‐Jin Chae, Jong‐Hyun Park, Octavian Henegariu, Saliha Yılmaz, Liming Hao, Alfred L.M. Bothwell · 2017 · Immunology
  99. Cancer as an ecomolecular disease and a neoplastic consortium
    Santiago Ramón y Cajal, Claudia Capdevila, Javier Hernández‐Losa, Leticia De Mattos‐Arruda, Abhishek Ghosh, Julie Lorent, Ola Segnestam Larsson, Trond Aasen, Lynne-Marie M Postovit, Ivan Topisirović · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  100. High expression of PU.1 is associated with Her‑2 and shorter survival in patients with breast cancer
    Jing Lin, Wei Liu, Tian Luan, Lili Yuan, Wei Jiang, Huilong Cai, Weiguang Yuan, Yuwen Wang, Qingyuan Zhang, Lihong Wang · 2017 · Oncology Letters